After Supreme Court Push, Centre To Cap Cancer Drug Margins At 30%

The Court however questioned why such a cap could not be imposed for all medicines.
Read the full story on LiveLaw Opens livelaw.in in a new tab
This is a short summary of a story published by LiveLaw, shown with a link to the original. The full story, photo and reporting belong to LiveLaw.











